Literature DB >> 11864909

SV40 T antigen and telomerase are required to obtain immortalized human adult bone cells without loss of the differentiated phenotype.

Christian Darimont1, Ornella Avanti, Yvonne Tromvoukis, Patricia Vautravers-Leone, Nori Kurihara, G David Roodman, Lorel M Colgin, Heide Tullberg-Reinert, Andrea M A Pfeifer, Elizabeth A Offord, Katherine Mace.   

Abstract

In most human primary bone cells, SV40 T-antigen expression was able to expand life span for a few passages before cells undergo growth arrest, described as crisis. In this study, telomerase activity was reconstituted in human osteoblast precursors (hPOB cells) and marrow stromal cells (Saka cells) transformed with the SV40 T antigen. Bone cells with telomerase activity were able to bypass crisis and show unlimited life span. Despite chromosomal aberrations observed in hPOB-tert cells, these immortalized precursors were able to differentiate into osteoblasts like precrisis hPOB cells. Saka-tert cells enhanced the formation of human osteoclast-like cells in a similar manner as Saka cells. These results demonstrate that reconstitution of telomerase activity in transformed SV40 T-antigen human osteoblast precursors or marrow stromal cells leads to the generation of immortalized cells with a preserved phenotype.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11864909

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  13 in total

1.  Development and characterization of a mouse floxed Bmp2 osteoblast cell line that retains osteoblast genotype and phenotype.

Authors:  Li-an Wu; Junsheng Feng; Lynn Wang; Yan-dong Mu; Andrew Baker; Kevin J Donly; Stephen E Harris; Mary MacDougall; Shuo Chen
Journal:  Cell Tissue Res       Date:  2011-01-27       Impact factor: 5.249

2.  Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis.

Authors:  Rachel M Locklin; Ermanno Federici; Belen Espina; Philippa A Hulley; R Graham G Russell; Claire M Edwards
Journal:  Mol Cancer Ther       Date:  2007-12-07       Impact factor: 6.261

Review 3.  Stem cell function and maintenance - ends that matter: role of telomeres and telomerase.

Authors:  Hamid Saeed; Mehwish Iqtedar
Journal:  J Biosci       Date:  2013-09       Impact factor: 1.826

4.  A cellular automata model of bone formation.

Authors:  Gabrielle K Van Scoy; Estee L George; Flora Opoku Asantewaa; Lucy Kerns; Marnie M Saunders; Alicia Prieto-Langarica
Journal:  Math Biosci       Date:  2017-02-09       Impact factor: 2.144

5.  Immortalization of human umbilical vein endothelial cells with telomerase reverse transcriptase and simian virus 40 large T antigen.

Authors:  Chang Bian; Kui Zhao; Guo-xin Tong; Yong-liang Zhu; Peng Chen
Journal:  J Zhejiang Univ Sci B       Date:  2005-07       Impact factor: 3.066

6.  Immortalization of human precartilaginous stem cells by transfecting SV40Tag.

Authors:  Junfang Wang; Huang Fang; Renyun Xia; Anming Chen; Hao Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-04-28

7.  CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment.

Authors:  Y Sambandam; K Sundaram; A Liu; K L Kirkwood; W L Ries; S V Reddy
Journal:  Oncogene       Date:  2012-02-13       Impact factor: 9.867

8.  Differentiation and Establishment of Dental Epithelial-Like Stem Cells Derived from Human ESCs and iPSCs.

Authors:  Gee-Hye Kim; Jihye Yang; Dae-Hyun Jeon; Ji-Hye Kim; Geun Young Chae; Mi Jang; Gene Lee
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

9.  Generation and characterization of feline arterial and venous endothelial cell lines for the study of the vascular endothelium.

Authors:  Dominique A J Olyslaegers; Lowiese M B Desmarets; Annelike Dedeurwaerder; Hannah L Dewerchin; Hans J Nauwynck
Journal:  BMC Vet Res       Date:  2013-08-29       Impact factor: 2.741

Review 10.  Therapeutic Targeting of Telomerase.

Authors:  Kathrin Jäger; Michael Walter
Journal:  Genes (Basel)       Date:  2016-07-21       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.